1. Home
  2. TRU vs MEDP Comparison

TRU vs MEDP Comparison

Compare TRU & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TransUnion

TRU

TransUnion

HOLD

Current Price

$84.15

Market Cap

16.5B

Sector

Finance

ML Signal

HOLD

Logo Medpace Holdings Inc.

MEDP

Medpace Holdings Inc.

HOLD

Current Price

$542.63

Market Cap

13.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRU
MEDP
Founded
1968
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Commercial Physical & Biological Resarch
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.5B
13.4B
IPO Year
2015
2016

Fundamental Metrics

Financial Performance
Metric
TRU
MEDP
Price
$84.15
$542.63
Analyst Decision
Buy
Hold
Analyst Count
12
12
Target Price
$104.45
$465.18
AVG Volume (30 Days)
1.7M
268.8K
Earning Date
10-23-2025
10-22-2025
Dividend Yield
0.55%
N/A
EPS Growth
87.22
25.36
EPS
2.14
14.32
Revenue
$4,441,800,000.00
$2,358,373,000.00
Revenue This Year
$9.59
$21.48
Revenue Next Year
$7.57
$11.90
P/E Ratio
$39.35
$37.77
Revenue Growth
8.30
13.88
52 Week Low
$66.38
$250.05
52 Week High
$101.42
$626.26

Technical Indicators

Market Signals
Indicator
TRU
MEDP
Relative Strength Index (RSI) 53.83 34.35
Support Level $82.16 $585.65
Resistance Level $85.61 $626.26
Average True Range (ATR) 2.12 18.47
MACD 0.18 -7.23
Stochastic Oscillator 69.48 12.29

Price Performance

Historical Comparison
TRU
MEDP

About TRU TransUnion

TransUnion is one of the three leading credit bureaus in the United States, providing the consumer information that is the basis for granting credit. The company also provides fraud detection, marketing, and analytical services. TransUnion operates in over 30 countries. About 20%-25% of its revenue comes from international markets.

About MEDP Medpace Holdings Inc.

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Share on Social Networks: